title: A case of gastric cancer with liver metastases had a complete response with cisplatin and capecitabine as third-line chemotherapy.
abstract: Advanced gastric cancer has a poor prognosis, and only chemotherapy improves survival. Further chemotherapy after progression is controversial. Eastern Cooperative Oncology Group performance status is an important indicator for new chemotherapy decision. Complete response (CR) after recurrent disease is very rare, but could occur in some cases with chemotherapy. The 68-year-old male received chemotherapy for metastatic gastric adenocarcinoma. He received epirubicin, cisplatin and fluorouracil in the first line, capecitabine in the second line and cisplatin-capecitabine in the third line. CR was observed after third-line chemotherapy with four courses. Mediastinal and abdominal metastases were completely resolved. We decided to report this patient because it is very unusual to achieve CR in a patient in whom the best supportive care might be reasonable.
authors.affiliation: Department of Medical Oncology, 19 Mayis University Medical Faculty, Samsun, Turkey.
authors.forename: Fatih
authors.initials: F
authors.lastname: Teker
authors.forename: Fevziye
authors.initials: F
authors.lastname: Canbaz
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Kemal
authors.forename: Idris
authors.initials: I
authors.lastname: Yucel
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D011379:Prognosis; D012074:Remission Induction; D016879:Salvage Therapy; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000069287:Capecitabine; D002945:Cisplatin